Pain Palliative Care
The government's White Paper Our Health, Our Option, Our Opinion, National Institute of Clinical Excellence Guidelines, and the Department of
Health End of Life Strategy highlighted end-of -
life care as a national priority. It is one of twelve national Quality, Innovation , Productivity, and Prevention (QIPP) priorities. One indicator associated with a 'good death' is whether patients are being cared for in their place of choice, and die. But patients can receive
palliative care at any time, whether it is terminal or not, at any stage of the illness. Instead of vigorous disease control, most initiatives concentrate on comfort. That when you can seek palliative care, there are no time limits, this helps to fill the void for patients who want and need support at any level of the illness, whether terminal or chronic.
High Impact List of Articles
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Emilio Perucca
Emilio Perucca
Interview: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
Relevant Topics in